Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2209 ARTÍCULOS , VIENDO DEL 46 AL 60

Remodeling of the brain immune microenvironment in Alzheimer's disease: interactions among microglia, astrocytes, complement, and the neurovascular unit

Wang T, Wang L, Cao J, Zhao Y, He Z, Lu F.

Front Immunol. 2026 Sep 28;17:1956600. doi: 10.3389/fimmu.2026.1956600. eCollection 2026.

Education as a proxy for cognitive reserve, and its moderating role in the amyloid-cognition relationship across the Alzheimer's disease continuum: A systematic review and meta-analysis

Yang Y, Zhang Y, Meliker JR, Richmond LL, Smith DM, Clouston SAP.

J Alzheimers Dis. 2026 Oct 13:13872877261496419. doi: 10.1177/13872877261496419. Online ahead of print.

"Morphological, Functional, and Molecular Progression of Blood-Brain Barrier Dysfunction in Alzheimer's Disease"

León-Arcia K, Martínez-Orozco H, Guerra-Crespo M, Díaz-Miranda SY, Soto-Rojas LO.

J Mol Neurosci. 2026 Oct 14;76(4):153. doi: 10.1007/s12031-026-02610-0.

Preclinical and first-in-human evaluation of VG-3927/SAR448851, an oral small-molecule TREM2 agonist for Alzheimer's disease

Dejanovic B, Figley MD, Weisman E, Kiragasi B, Gergits FW, Larson K, Renoux A, Rajagovindan R, Pandya B, Houze J, Huang L, Gaudreault F, O'Mara R, Clarkson JH, Turnbull MT, Meier A, Colonna M, Stromme J, Gray D, Thackaberry EA, Kaufmann P, Mirescu C.

Sci Transl Med. 2026 Oct 14;18(871):eaec5740. doi: 10.1126/scitranslmed.aec5740. Epub 2026 Oct 14.

Molecular Pathogenesis of Cerebral Amyloid Angiopathy in Alzheimer's Disease: The Role of the Central Fibrinolytic Cascade at the Neurovascular Unit

Kumar S, Paswan SK, Verma P, Chaturvedi S, Vishwakarma VK, Yadav HN.

Mol Neurobiol. 2026 Oct 15;63(1):969. doi: 10.1007/s12035-026-06263-3.

From Amyloid Exposure to Genetic Causality: Converging hiPSC-Based Models of Alzheimer's Disease

Colasuonno F, Valenza A, Rossin F, Moreno S.

Cells. 2026 Sep 30;15(19):1793. doi: 10.3390/cells15191793.

HMGB1 in Amyloid-Beta Pathology: Mechanistic Insights and Therapeutic Implications for Alzheimer's Disease

Seol SI, Kim JE, Davaanyam D, Park SY, Lee EH, Han PL, Kim TK, Lee JK.

Int J Mol Sci. 2026 Sep 28;27(19):8681. doi: 10.3390/ijms27198681.

The Adult Neurogenesis Theory of Alzheimer's Disease Predicts Where Tauopathy Develops in the Brain

Abbate C.

Int J Mol Sci. 2026 Sep 30;27(19):8776. doi: 10.3390/ijms27198776.

Amyloid-β Immunotherapy in Alzheimer's Disease: Challenges and Opportunities

Nakashima S, Sato K, Niimi Y, Iwatsubo T.

Annu Rev Pathol. 2026 Oct 16. doi: 10.1146/annurev-pathmechdis-032025-030232. Online ahead of print.

CD8(+) t cell-mediated regulation of synaptic integrity in Alzheimer's disease

Fu H, Yang J, Zhang M.

Front Immunol. 2026 Oct 1;17:1903001. doi: 10.3389/fimmu.2026.1903001. eCollection 2026.

Should ApoE4 gene editing therapy be approached with caution when AD is accompanied by retinal neurodegenerative diseases?

Wenhua Y, Wenjing M, Yan D, Fei L, Juan C, Xia T, Yu G, Xin L, Yanlin H, Ya G, Xuelin Y, Jing L, Meimin J, Wenyi L, Yilin K, Hongke L, Yating L.

Front Neurol. 2026 Oct 1;17:1934307. doi: 10.3389/fneur.2026.1934307. eCollection 2026.

Ethical challenges in the clinical translation of anti-amyloid monoclonal antibodies for Alzheimer's disease: a scoping review

Wicker A, Courtright-Lim A, Tilburt J.

Front Psychiatry. 2026 Oct 5;17:1953954. doi: 10.3389/fpsyt.2026.1953954. eCollection 2026.

Cannabidiol in Alzheimer's disease: evidence-weighted molecular mechanisms and translational challenges

Sura S, Jagadeesan S, Masrudin SS, Moklas MAM, Nor NHM.

Mol Biol Rep. 2026 Oct 23;53(1):1792. doi: 10.1007/s11033-026-13034-9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias